Sunovion announces u.s. fda approval of kynmobi™ (apomorphine hydrochloride) sublingual film for the treatment of parkinson’s disease off episodes

Sunovion announces the fda approval of kynmobi for off episodes associated with parkinson's disease

HCI Ratings Summary

HCI Quant Ranking